ClinicalTrials.Veeva

Menu

T Wave Alternans in Hemodialysis

I

Indiana University School of Medicine

Status

Completed

Conditions

Coronary Heart Disease
End Stage Renal Disease
Congestive Heart Failure

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00296543
0508-02

Details and patient eligibility

About

The purpose of this study is to determine if the hemodialysis procedure changes the risk for cardiac arrest in patients.

Full description

One-third to one-quarter of hemodialysis patients die of sudden cardiac death (SCD). The hemodialysis procedure may theoretically increase the risk of SCD. This study uses T wave alternans, a noninvasive marker of SCD, to objectively determine whether the hemodialysis procedure alters the risk of SCD in hemodialysis patients.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or older
  • Normal sinus rhythm

Exclusion criteria

  • Inability to give written informed consent
  • Active cardiac ischemia
  • Pacemaker
  • Inability to perform a brief walking treadmill test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems